Pitavastatin decreases serum LOX-1 ligand levels and MT1-MMP expression in CD14-positive mononuclear cells in hypercholesterolemic patients

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2014-10, Vol.176 (3), p.1230-1232
Main Authors: Uzui, Hiroyasu, Hayashi, Hideki, Nakae, Izuru, Matsumoto, Tetsuya, Uenishi, Hiroaki, Hayasaki, Hisae, Asaji, Takayoshi, Matsui, Shinobu, Miwa, Kunihisa, Lee, Jong-Dae, Tada, Hiroshi, Sawamura, Tatsuya, Fujita, Masatoshi
Format: Article
Language:English
Subjects:
Cardiovascular
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypercholesterolemia - blood
Hypercholesterolemia - drug therapy
Hypercholesterolemia - immunology
Leukocytes, Mononuclear - immunology
Ligands
Lipopolysaccharide Receptors - immunology
LOX-1 ligand
Male
Matrix Metalloproteinase 14 - biosynthesis
Middle Aged
MT1-MMP
Pitavastatin
Plaque vulnerability
Quinolines - therapeutic use
Scavenger Receptors, Class E - blood
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2014.07.213